Quick Takeaways
- Point72 Asset Management, L.P. filed SCHEDULE 13G/A for LENZ Therapeutics, Inc. Common Stock, par value $0.00001 per share (LENZ).
- Disclosed ownership: 4.8%.
- Date of event: 30 Sep 2025.
Quoteable Key Fact
"Point72 Asset Management, L.P. disclosed 4.8% ownership in LENZ Therapeutics, Inc. Common Stock, par value $0.00001 per share (LENZ) on 30 Sep 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 1.2% | 340,000 | 0 | 340,000 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Capital Advisors, Inc. | 1.2% | 340,000 | 0 | 340,000 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Biotech Private Investments, LLC | 3.6% | 1,017,751 | 0 | 1,017,751 | /s/ Vincent Tortorella | Vincent Tortorella, Authorized Person | |
| Differentiated Ventures Investments, LLC | 3.6% | 1,017,751 | 0 | 1,017,751 | /s/ Vincent Tortorella | Vincent Tortorella, Authorized Person | |
| 72 Investment Holdings, LLC | 3.6% | 1,017,751 | 0 | 1,017,751 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Steven A. Cohen | 4.8% | 1,357,751 | 0 | 1,357,751 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person |